Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19
Gene-Editing Biotechs Pop After Pfizer Partner Scores In Hemophilia AInvestors Business Daily • 04/02/19